54-year-old female with history of cervical/uterine neoplasm who presents for evaluation. PELVIS:UTERUS, ADNEXA: There is a T1/T2 heterogeneous mass within the cervix and the uterus with extension into the upper vagina. When compared to the 2/26/2016 MRI examination, there has been interval increase in the heterogeneity of the mass, likely related to radiation treatment. As compared on the sagittal images, there has been interval decrease in the tumor bulk which measures 2.1 x 3.6 (series 401, image 45) on the current examination and previously measuring 8.3 x 3.4 cm. The bulk of the tumor is hypoenhancing making it difficult to demarcate to the uterine portion of the tumor.In the region of the right ovary, there are T1 hyperintense, T2 low to intermediate signal, nonenhancing foci with the largest measuring 3.0 x 3.5 cm (series 801, image 29), previously measuring 3.3 x 3.2 cm (series 9, image 38). The signal characteristics of these 2 foci are not significantly changed compared to the previous examination. BLADDER: No significant abnormality noted.LYMPH NODES: No definite lymphadenopathy.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Interval treatment/radiation make difficult to demarcate the cervical/uterine tumor. However, as compared on the sagittal images, there has been significant reduction in the tumor bulk as detailed above.2.In the region of the right adnexa, T1 hyperintense, nonenhancing foci are identified as detailed above. Differential considerations include hemorrhagic cyst versus endometriomas.